vidarabine has been researched along with Lymphoma, B-Cell, Marginal Zone in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (58.33) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, S; Olszewski, AJ; Shafqat, H | 1 |
| Argnani, L; Broccoli, A; Casadei, B; Gandolfi, L; Maglie, R; Pellegrini, C; Pileri, S; Stefoni, V; Zinzani, PL | 1 |
| Fan, L; Li, JY; Min, K; Wang, L; Wu, JZ; Xu, J; Xu, W | 1 |
| Donaldson, SL; McGonagle, DG; Owen, RG | 1 |
| Thieblemont, C | 1 |
| Brown, JR; Dal Cin, P; Feng, Y; Fisher, DC; Fisher, RI; Freedman, AS; Friedberg, JW; Joyce, R; Liesveld, J; Marquis, D; Neuberg, D; Phillips, K; Scofield, S; Takvorian, RW | 1 |
| Carney, D; Januszewicz, EH; Peinert, S; Prince, HM; Seymour, JF | 1 |
| Canales, MA; Domingo-Domenech, E; Estany, C; Fraile, G; Gallardo, F; Montalbán, C; Salar, A; Servitje, O | 1 |
| Bayer, R; Fung, HC; Gregory, SA; Karmali, R; Kassar, M; O'Brien, T; Shammo, JM; Venugopal, P | 1 |
| Huynh, M; Neubauer, A | 1 |
| Aleman, BM; Boot, H; de Boer, JP; de Jong, D; Raderer, M; van Tinteren, H | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Casadei, B; Celli, M; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Pileri, S; Poletti, V; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
| Chevret, S; Choquet, S; Copplestone, A; Dartigeas, C; Dilhuydy, MS; Ewings, M; Johnson, S; Leblond, V; Lejeune, J; Malphettes, M; Morel, P; Nguyen-Khac, F; Owen, RG; Patmore, RD; Pratt, G; Royer, B; Rule, S; Seymour, JF; Tournilhac, O; Willoughby, S; Wright, D | 1 |
| Castillo, JJ; Olszewski, AJ | 1 |
| Arcache, J; Arnaud, P; Berger, F; Callet-Bauchu, E; Coiffier, B; Dumontet, C; Felman, P; Hequet, O; Salles, G; Thieblemont, C | 1 |
| Alinari, L; Baccarani, M; Gabriele, A; Marchi, E; Musuraca, G; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Drage, NA; Howarth, A; Wickramasinghe, A | 1 |
| Boudreaux, CW; Michael, CW; Richardson, PH | 1 |
| Arkenau, HT; Chau, I; Cunningham, D; Gordon, C; Norman, A; Wotherspoon, A | 1 |
| Bettembourg, O; Cochard, C; Cochener, B; Roussel, B | 1 |
| Anagnostopoulos, A; Dimopoulos, MA; Economopoulos, T; Fountzilas, G; Papageorgiou, S; Psyrri, A; Tsatalas, C; Xiros, N | 1 |
| Chen, L; Lü, SQ; Ni, X; Song, XM; Wang, JM; Xu, XQ; Yang, JM; Zhang, WP | 1 |
| Hamdi, S; Huguet, F; Laporte, F; Oksman, F | 1 |
| Boguszewski, CL; Collaço, LM; Graf, H; Neto, JZ; Nomura, LM; Pereira, FO | 1 |
3 review(s) available for vidarabine and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Plasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literature.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large-Cell, Immunoblastic; Male; Neoplasms, Second Primary; Rituximab; Vidarabine | 2014 |
Non-MALT marginal zone lymphomas.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antineoplastic Agents; beta 2-Microglobulin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Italy; L-Lactate Dehydrogenase; Lymph Nodes; Lymphocytosis; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prognosis; Splenectomy; Splenic Neoplasms; Survival Analysis; Vidarabine | 2008 |
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomycin; Bone Marrow; Bone Marrow Diseases; Chemotherapy, Adjuvant; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Paraproteins; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Splenectomy; Splenic Neoplasms; Survival Analysis; Treatment Outcome; Vidarabine; Vincristine | 2002 |
5 trial(s) available for vidarabine and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoproliferative Disorders; Male; Middle Aged; Prospective Studies; Rituximab; Survival Rate; Vidarabine | 2009 |
Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Rituximab; Vidarabine | 2009 |
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Radiopharmaceuticals; Rituximab; Survival Analysis; Vidarabine; Yttrium Radioisotopes | 2011 |
Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Topics: Aged; Antineoplastic Agents; Chlorambucil; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Proportional Hazards Models; Vidarabine; Waldenstrom Macroglobulinemia | 2013 |
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Remission Induction; Treatment Outcome; Vidarabine | 2008 |
16 other study(ies) available for vidarabine and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Febrile Neutropenia; Female; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Male; Outcome Assessment, Health Care; Prednisone; Rituximab; SEER Program; Survival Analysis; United States; Vidarabine; Vincristine | 2015 |
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Therapy; Female; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine | 2015 |
Prolonged remission of marginal zone lymphoma in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor agents.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha; Vidarabine | 2014 |
Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?
Topics: Adult; Aged; Aged, 80 and over; Anemia, Refractory; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bone Marrow Diseases; Cell Lineage; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Rituximab; Vidarabine | 2009 |
Gastric mucosa-associated lymphoid tissue lymphoma: how to attack the T… for two?
Topics: Antineoplastic Agents; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Tumor Microenvironment; Vidarabine | 2011 |
Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; T-Lymphocyte Subsets; Tumor Microenvironment; Vidarabine | 2011 |
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Disease-Free Survival; Drug Evaluation; Female; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Mitoxantrone; Radionuclide Imaging; Retrospective Studies; Treatment Outcome; Vidarabine | 2013 |
Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Medicare; Middle Aged; Risk Factors; Rituximab; SEER Program; Survival Rate; Treatment Outcome; United States; Vidarabine | 2013 |
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vidarabine; Vincristine | 2004 |
Multiple bilateral parotid sialoliths in a patient with mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) of the salivary glands.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Mitoxantrone; Parotid Diseases; Parotid Neoplasms; Prednisone; Salivary Gland Calculi; Sjogren's Syndrome; Stomach Neoplasms; Submandibular Gland; Ultrasonography; Vidarabine; Vincristine | 2005 |
Pulmonary lymphoma of the mucosa-associated lymphoid tissue type: Report of a case with cytological, histological, immunophenotypical correlation, and review of the literature.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Humans; Immunophenotyping; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Treatment Outcome; Vidarabine; Vincristine | 2005 |
Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine | 2007 |
[MALT (mucosa-associated lymphoid tissue) lymphoma of the lacrimal gland].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Eye Neoplasms; Humans; Lacrimal Apparatus; Lymphoma, B-Cell, Marginal Zone; Male; Mitoxantrone; Rituximab; Vidarabine | 2007 |
[A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Thrombocytopenia; Vidarabine | 2007 |
Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma.
Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Granulocytes; Humans; Hypoglycemic Agents; Leukocyte Count; Lymphoma, B-Cell, Marginal Zone; Male; Metformin; Neutropenia; Splenic Neoplasms; Vidarabine | 2008 |
Concomitant presentation of Hashimoto's thyroiditis and maltoma of the thyroid in a twenty-year-old man with a rapidly growing mass in the neck.
Topics: Adult; Antineoplastic Agents; Autoantibodies; Humans; Iodide Peroxidase; Lymphoma, B-Cell, Marginal Zone; Male; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyroiditis, Autoimmune; Thyrotropin; Thyroxine; Triiodothyronine; Vidarabine | 2000 |